21-5710. Unlawful distribution of certain drug precursors and drug paraphernalia.

672 words·~3 min read·/ks/chapter-21/21-5710

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)It shall be unlawful for any person to advertise, market, label, distribute or possess with the intent to distribute:

(1)Any product containing ephedrine, pseudoephedrine, red phosphorus, lithium metal, sodium metal, iodine, anhydrous ammonia, pressurized ammonia or phenylpropanolamine or their salts, isomers or salts of isomers if the person knows or reasonably should know that the purchaser will use the product to manufacture a controlled substance or controlled substance analog; or

(2)any product containing ephedrine, pseudoephedrine or phenylpropanolamine, or their salts, isomers or salts of isomers for indication of stimulation, mental alertness, weight loss, appetite control, energy or other indications not approved pursuant to the pertinent federal over-the-counter drug final monograph or tentative final monograph or approved new drug application.

(b)It shall be unlawful for any person to distribute, possess with the intent to distribute or manufacture with intent to distribute any drug paraphernalia, knowing or under circumstances where one reasonably should know that it will be used to manufacture or distribute a controlled substance or controlled substance analog in violation of K.S.A. 21-5701 through 21-5717 , and amendments thereto.

(c)It shall be unlawful for any person to distribute, possess with intent to distribute or manufacture with intent to distribute any drug paraphernalia, knowing or under circumstances where one reasonably should know, that it will be used as such in violation of K.S.A. 21-5701 through 21-5717 , and amendments thereto, except subsection

(b)of K.S.A. 21-5706 , and amendments thereto.

(d)It shall be unlawful for any person to distribute, possess with intent to distribute or manufacture with intent to distribute any drug paraphernalia, knowing, or under circumstances where one reasonably should know, that it will be used as such in violation of subsection

(b)of K.S.A. 21-5706 , and amendments thereto.

(1)Violation of subsection

(a)is a drug severity level 3 felony;

(2)violation of subsection

(b)is a:

(A)Drug severity level 5 felony, except as provided in subsection (e)(2)(B); and

(B)drug severity level 4 felony if the trier of fact makes a finding that the offender distributed or caused drug paraphernalia to be distributed to a minor or on or within 1,000 feet of any school property;

(3)violation of subsection

(c)is a:

(A)Nondrug severity level 9, nonperson felony, except as provided in subsection (e)(3)(B); and

(B)drug severity level 5 felony if the trier of fact makes a finding that the offender distributed or caused drug paraphernalia to be distributed to a minor or on or within 1,000 feet of any school property; and

(4)violation of subsection

(d)is a:

(A)Class A nonperson misdemeanor, except as provided in subsection (e)(4)(B); and

(B)nondrug severity level 9, nonperson felony if the trier of fact makes a finding that the offender distributed or caused drug paraphernalia to be distributed to a minor or on or within 1,000 feet of any school property.

(f)For persons arrested and charged under subsection (a), bail shall be at least $50,000 cash or surety, and such person shall not be released upon the person's own recognizance pursuant to K.S.A. 22-2802 , and amendments thereto, unless the court determines, on the record, that the defendant is not likely to re-offend, the court imposes pretrial supervision or the defendant agrees to participate in a licensed or certified drug treatment program.

(g)As used in this section, "or under circumstances where one reasonably should know" that an item will be used in violation of this section, shall include, but not be limited to, the following:

(1)Actual knowledge from prior experience or statements by customers;

(2)inappropriate or impractical design for alleged legitimate use;

(3)receipt of packaging material, advertising information or other manufacturer supplied information regarding the item's use as drug paraphernalia; or

(4)receipt of a written warning from a law enforcement or prosecutorial agency having jurisdiction that the item has been previously determined to have been designed specifically for use as drug paraphernalia.